FDA’s Peter Stein And Lessons From Makena: There Are Limits To Regulatory Flexibility

 
• By Sarah Karlin-Smith
  
Makena - Nguyen and Stein
CDER’s Nguyen and Stein wrap up a persuasive round of ‘cross-examination’ of Covis at Makena hearing • Source: Screenshot of FDA hearing
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers